{"altmetric_id":13204318,"counts":{"readers":{"mendeley":9,"citeulike":0,"connotea":0},"total":{"posts_count":10},"news":{"unique_users_count":8,"unique_users":["biz_wire_express","device_space","stock_nod_quotes","minyanville_finance","benzinga","yahoo_finance_usa","biospace","nasdaq"],"posts_count":10}},"citation":{"altmetric_jid":"4f6fa5ea3cf058f610005add","authors":["K. Suzuki"],"doi":"10.12968\/jowc.2016.25.sup10.s25","endpage":"S31","first_seen_on":"2016-10-31T20:33:24+00:00","issns":["0969-0700","2052-2916"],"issue":"Sup10","journal":"Journal of Wound Care","last_mentioned_on":1478362959,"links":["http:\/\/dx.doi.org\/10.12968\/jowc.2016.25.Sup10.S25"],"pubdate":"2016-10-01T00:00:00+00:00","publisher_subjects":[{"name":"Nursing","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"S25","title":"Viable intact cryopreserved human placental membrane for a non-surgical approach to closure in complex wounds","type":"article","volume":"25","mendeley_url":"http:\/\/www.mendeley.com\/research\/viable-intact-cryopreserved-human-placental-membrane-nonsurgical-approach-closure-complex-wounds"},"altmetric_score":{"score":57,"score_history":{"1y":57,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":57},"context_for_score":{"all":{"total_number_of_other_articles":7651252,"mean":6.5763358914726,"rank":136941,"this_scored_higher_than_pct":98,"this_scored_higher_than":7514080,"rank_type":"exact","sample_size":7651252,"percentile":98},"similar_age_3m":{"total_number_of_other_articles":234293,"mean":12.793796843255,"rank":10050,"this_scored_higher_than_pct":95,"this_scored_higher_than":224220,"rank_type":"exact","sample_size":234293,"percentile":95},"this_journal":{"total_number_of_other_articles":246,"mean":3.1081224489796,"rank":1,"this_scored_higher_than_pct":99,"this_scored_higher_than":245,"rank_type":"exact","sample_size":246,"percentile":99},"similar_age_this_journal_3m":{"total_number_of_other_articles":11,"mean":3.918,"rank":1,"this_scored_higher_than_pct":90,"this_scored_higher_than":10,"rank_type":"exact","sample_size":11,"percentile":90}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":2,"Student  > Postgraduate":2,"Student  > Master":2,"Student  > Bachelor":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":1,"Agricultural and Biological Sciences":2,"Nursing and Health Professions":3,"Biochemistry, Genetics and Molecular Biology":2,"Chemical Engineering":1}}}},"posts":{"news":[{"title":"Peer-reviewed Publication on the use of Grafix\u00ae Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware","url":"http:\/\/ct.moreover.com\/?a=28460361011&p=1pl&v=1&x=SmXk1_1utO1ANpvFlTDO8Q","license":"public","citation_ids":[13204318],"posted_on":"2016-10-31T20:55:57+00:00","summary":"GlobeNewswire 2016-10-31 COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc.","author":{"name":"Biz Wire Express","url":"http:\/\/www.bizwireexpress.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/795\/normal\/Screen_Shot_2016-01-27_at_09.34.21.png?1453887297"}},{"title":"Osiris Release Peer Reviewed Publication On The Use Of Grafix Prime For Outpatient Management Of Complex Wounds With Exposed Bone Tendon Muscle Joint","url":"http:\/\/www.devicespace.com\/news_story.aspx?StoryID=437625&full=1","license":"public","citation_ids":[13204318],"posted_on":"2016-11-01T00:00:00+00:00","summary":"11\/1\/2016 11:08:56 AM COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc.","author":{"name":"Device Space","url":"http:\/\/www.devicespace.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/840\/normal\/Screen_Shot_2016-02-02_at_15.36.30.png?1454427403"}},{"title":"Peer-reviewed Publication on the use of Grafix\u00ae Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware","url":"http:\/\/ct.moreover.com\/?a=28460202251&p=1pl&v=1&x=DROfXPS4mIS8_-QsftNevw","license":"public","citation_ids":[13204318],"posted_on":"2016-10-31T20:30:00+00:00","summary":"COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) --. (NASDAQ:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopaedics and sports medicine, announced today that a new peer-reviewed\u2026","author":{"name":"Stock Nod: Quotes","url":"http:\/\/quotes.stocknod.com\/stocknod","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/671\/normal\/Screen_Shot_2016-01-26_at_13.59.47.png?1453816868"}},{"title":"Peer-reviewed Publication on the use of Grafix\u00ae Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware","url":"http:\/\/ct.moreover.com\/?a=28460228235&p=1pl&v=1&x=7qVr6fuRp5cdrEyQZkdOsQ","license":"public","citation_ids":[13204318],"posted_on":"2016-10-31T20:30:00+00:00","summary":"Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopaedics and sports medicine, announced today that a new peer-reviewed manuscript by Kazu Suzuki, DPM\u2026","author":{"name":"Minyanville: Finance ","url":"http:\/\/finance.minyanville.com\/minyanville","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/637\/normal\/Screen_Shot_2016-02-02_at_16.44.51.png?1454431502"}},{"title":"Peer-reviewed Publication on the use of Grafix\u00ae Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware","url":"http:\/\/ct.moreover.com\/?a=28460253506&p=1pl&v=1&x=ZS33cq-zxOj2ss10_fg2iA","license":"public","citation_ids":[13204318],"posted_on":"2016-10-31T20:40:38+00:00","summary":"COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- (NASDAQ: OSIR ), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopaedics and sports medicine, announced today that a new peer-reviewed\u2026","author":{"name":"Benzinga","url":"http:\/\/www.benzinga.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/738\/normal\/Screen_Shot_2016-01-26_at_15.59.27.png?1453824001"}},{"title":"Peer-reviewed Publication on the use of Grafix\u00ae Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware","url":"http:\/\/ct.moreover.com\/?a=28460278697&p=1pl&v=1&x=dHCRiqV38p1u73bNq3VpOg","license":"public","citation_ids":[13204318],"posted_on":"2016-10-31T20:30:00+00:00","summary":"COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. ( OSIR ), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopaedics and sports medicine, announced today that a new\u2026","author":{"name":"Yahoo! Finance USA","url":"http:\/\/finance.yahoo.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/620\/normal\/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}},{"title":"Peer-reviewed Publication on the use of Grafix\u00ae Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware","url":"http:\/\/ct.moreover.com\/?a=28460284909&p=1pl&v=1&x=F9KFe6b4JPXPS-6jE_Lbyw","license":"public","citation_ids":[13204318],"posted_on":"2016-10-31T20:30:00+00:00","summary":"COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. ( OSIR ), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopaedics and sports medicine, announced today that a new\u2026","author":{"name":"Yahoo! Finance USA","url":"http:\/\/finance.yahoo.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/620\/normal\/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}},{"title":"Peer-reviewed Publication on the use of Grafix\u00ae Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware","url":"http:\/\/ct.moreover.com\/?a=28460346645&p=1pl&v=1&x=-WHKm8b9ahsWPvkxbNs-LA","license":"public","citation_ids":[13204318],"posted_on":"2016-10-31T20:30:00+00:00","summary":"COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopaedics and sports medicine, announced today that a new peer-r\u2026","author":{"name":"Yahoo! Finance USA","url":"http:\/\/finance.yahoo.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/620\/normal\/Screen_Shot_2016-01-07_at_10.14.50.png?1452161734"}},{"title":"Osiris Release: Peer-Reviewed Publication On The Use Of Grafix Prime For Outpatient Management Of Complex Wounds With Exposed Bone, Tendon, Muscle, Joint, And Hardware","url":"http:\/\/ct.moreover.com\/?a=28469802748&p=1pl&v=1&x=54CRx0gZjzSQ-EcHQSwN7w","license":"public","citation_ids":[13204318],"posted_on":"2016-11-01T00:00:00+00:00","summary":"COLUMBIA, Md., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR ), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopaedics and sports medicine, announced today that a\u2026","author":{"name":"Biospace","url":"http:\/\/www.biospace.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/375\/normal\/biospace.png?1437140433"}},{"title":"Osiris to Present Clinical and Scientific Studies at Symposium on Advanced Wound Care (SAWC)","url":"http:\/\/ct.moreover.com\/?a=28511837070&p=1pl&v=1&x=8fOX2LvtsBKf40Vq6pOUIg","license":"public","citation_ids":[13204318],"posted_on":"2016-11-05T16:22:39+00:00","summary":"COLUMBIA, Md., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine\u2026","author":{"name":"NASDAQ","url":"http:\/\/www.nasdaq.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/839\/normal\/Screen_Shot_2016-01-27_at_11.14.52.png?1453893369"}}]}}